C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica. Phuan P-W, Zhang H, Asavapanumas N, Leviten M, Rosenthal A, Tradtrantip L, Verkman AS Acta Neuropathol. 2013 Jun; 125(6):829-840. Epub 2013 May 16. PMID: 23677375. Abstract CommentRecommendBookmarkWatch